Yichao Zhao

Yichao Zhao

Auto-generated profile, based on publicly available information

Yichao Zhao

David H Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 January 2022 in Science Advances
Verified
Journal Article
Open access
BWBo Wang
Bo Wang
CZChuanzhen Zhao
Chuanzhen Zhao
ZWZhaoqing Wang
Zhaoqing Wang
KYKyung-Ae Yang
Kyung-Ae Yang
XCXuanbing Cheng
Xuanbing Cheng
SESam Emaminejad
Sam Emaminejad
A smartwatch was developed for noninvasive stress biomarker data acquisition that provides real-time feedback to the wearer.

23 September 2022 in Science Advances
Verified
Journal Article
Open access
SLShuyu Lin
Shuyu Lin
XCXuanbing Cheng
Xuanbing Cheng
JZJialun Zhu
Jialun Zhu
BWBo Wang
Bo Wang
DJDavid Jelinek
David Jelinek
SESam Emaminejad
Sam Emaminejad
Therapeutic drug monitoring is essential for dosing pharmaceuticals with narrow therapeutic windows. Nevertheless, standard methods are imprecise and involve invasive/resource-intensive procedures with long turnaround times. Overcoming these limitations, we present a microneedle-based electrochemical aptamer biosensing patch (μNEAB-patch) that minimally invasively probes the interstitial fluid (ISF) and renders correlated, continuous, and real-time measurements of the circulating drugs’ pharmacokinetics. The μNEAB-patch is created following an introduced low-cost fabrication scheme, which transforms a shortened clinical-grade needle into a high-quality gold nanoparticle-based substrate for robust aptamer immobilization and efficient electrochemical signal retrieval. This enables the reliable in vivo detection of a wide library of ISF analytes—especially those with nonexistent natural recognition elements. Accordingly, we developed μNEABs targeting various drugs, including antibiotics with narrow therapeutic windows (tobramycin and vancomycin). Through in vivo animal studies, we demonstrated the strong correlation between the ISF/circulating drug levels and the device’s potential clinical use for timely prediction of total drug exposure.

20 March 2020 in Science Advances
Verified
Journal Article
Open access
PDF file
YZYichao Zhao
Yichao Zhao
BWBo Wang
Bo Wang
HHHannaneh Hojaiji
Hannaneh Hojaiji
ZWZhaoqing Wang
Zhaoqing Wang
SLShuyu Lin
Shuyu Lin
SESam Emaminejad
Sam Emaminejad
We devised a strategy for high-fidelity, wearable biomarker data acquisition and sensor integration with consumer electronics.

16 December 2022 in Science
Verified
Journal Article
Closed access
YZYichao Zhao
Yichao Zhao
BWBo Wang
Bo Wang
JTJiawei Tan
Jiawei Tan
HYHexing Yin
Hexing Yin
RHRuyi Huang
Ruyi Huang
SESam Emaminejad
Sam Emaminejad
Advancing electronics to interact with tissue necessitates meeting material constraints in electrochemical, electrical, and mechanical domains simultaneously. Clinical bioelectrodes with established electrochemical functionalities are rigid and mechanically mismatched with tissue. Whereas conductive materials with tissue-like softness and stretchability are demonstrated, when applied to electrochemically probe tissue, their performance is distorted by strain and corrosion. We devise a layered architectural composite design that couples strain-induced cracked films with a strain-isolated out-of-plane conductive pathway and in-plane nanowire networks to eliminate strain effects on device electrochemical performance. Accordingly, we developed a library of stretchable, highly conductive, and strain-insensitive bioelectrodes featuring clinically established brittle interfacial materials (iridium-oxide, gold, platinum, and carbon). We paired these bioelectrodes with different electrochemical probing methods (amperometry, voltammetry, and potentiometry) and demonstrated strain-insensitive sensing of multiple biomarkers and in vivo neuromodulation.

27 July 2020 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
SLShuyu Lin
Shuyu Lin
WYWenzhuo Yu
Wenzhuo Yu
BWBo Wang
Bo Wang
YZYichao Zhao
Yichao Zhao
KEKe En
Ke En
SESam Emaminejad
Sam Emaminejad
To achieve the mission of personalized medicine, centering on delivering the right drug to the right patient at the right dose, therapeutic drug monitoring solutions are necessary. In that regard, wearable biosensing technologies, capable of tracking drug pharmacokinetics in noninvasively retrievable biofluids (e.g., sweat), play a critical role, because they can be deployed at a large scale to monitor the individuals’ drug transcourse profiles (semi)continuously and longitudinally. To this end, voltammetry-based sensing modalities are suitable, as in principle they can detect and quantify electroactive drugs on the basis of the target’s redox signature. However, the target’s redox signature in complex biofluid matrices can be confounded by the immediate biofouling effects and distorted/buried by the interfering voltammetric responses of endogenous electroactive species. Here, we devise a wearable voltammetric sensor development strategy—centering on engineering the molecule–surface interactions—to simultaneously mitigate biofouling and create an “undistorted potential window” within which the target drug’s voltammetric response is dominant and interference is eliminated. To inform its clinical utility, our strategy was adopted to track the temporal profile of circulating acetaminophen (a widely used analgesic and antipyretic) in saliva and sweat, using a surface-modified boron-doped diamond sensing interface (cross-validated with laboratory-based assays, R2 ∼ 0.94). Through integration of the engineered sensing interface within a custom-developed smartwatch, and augmentation with a dedicated analytical framework (for redox peak extraction), we realized a wearable solution to seamlessly render drug readouts with minute-level temporal resolution. Leveraging this solution, we demonstrated the pharmacokinetic correlation and significance of sweat readings. Significance To achieve the mission of personalized medicine, centering on delivering the right drug to the right patient at the right dose, therapeutic drug monitoring solutions are necessary. By devising a surface engineering strategy, we created a voltammetric sensing interface, featuring an “undistorted potential window,” within which the target electroactive drug’s voltammetric response is dominant and interference is eliminated, rendering reliable target quantification in noninvasively retrievable biofluids (sweat and saliva). Leveraging this sensing interface, a fully integrated, wearable solution was constructed to seamlessly render drug readouts with minute-level temporal resolution. To inform its clinical utility, the solution was utilized to demonstrate noninvasive pharmacokinetic monitoring of a pharmaceutical (here, acetaminophen, a widely used analgesic and antipyretic) in a wearable format.

7 March 2023 in Biomaterials
Verified
Journal Article
Closed access
Yangzhi ZhuYangzhi Zhu
Yangzhi Zhu
JLJinghang Li
Jinghang Li
JKJinjoo Kim
Jinjoo Kim
SLShaopei Li
Shaopei Li
YZYichao Zhao
Yichao Zhao
Ali  KhademhosseiniAli Khademhosseini
Ali Khademhosseini